vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $164.7M, roughly 1.4× PTC THERAPEUTICS, INC.). CROSS COUNTRY HEALTHCARE INC runs the higher net margin — -35.0% vs -82.0%, a 46.9% gap on every dollar of revenue. On growth, PTC THERAPEUTICS, INC. posted the faster year-over-year revenue change (-22.7% vs -23.6%). CROSS COUNTRY HEALTHCARE INC produced more free cash flow last quarter ($16.1M vs $-36.6M). Over the past eight quarters, PTC THERAPEUTICS, INC.'s revenue compounded faster (-11.5% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
CCRN vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $164.7M |
| Net Profit | $-82.9M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | -30.2% | -43.3% |
| Net Margin | -35.0% | -82.0% |
| Revenue YoY | -23.6% | -22.7% |
| Net Profit YoY | -2109.7% | -104.8% |
| EPS (diluted) | $-2.56 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $164.7M | ||
| Q3 25 | $250.1M | $211.0M | ||
| Q2 25 | $274.1M | $178.9M | ||
| Q1 25 | $293.4M | $1.2B | ||
| Q4 24 | $309.9M | $213.2M | ||
| Q3 24 | $315.1M | $196.8M | ||
| Q2 24 | $339.8M | $186.7M | ||
| Q1 24 | $379.2M | $210.1M |
| Q4 25 | $-82.9M | $-135.0M | ||
| Q3 25 | $-4.8M | $15.9M | ||
| Q2 25 | $-6.7M | $-64.8M | ||
| Q1 25 | $-490.0K | $866.6M | ||
| Q4 24 | $-3.8M | $-65.9M | ||
| Q3 24 | $2.6M | $-106.7M | ||
| Q2 24 | $-16.1M | $-99.2M | ||
| Q1 24 | $2.7M | $-91.6M |
| Q4 25 | — | — | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 20.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 20.4% | — | ||
| Q2 24 | 20.8% | — | ||
| Q1 24 | 20.4% | — |
| Q4 25 | -30.2% | -43.3% | ||
| Q3 25 | -2.4% | 1.4% | ||
| Q2 25 | -2.1% | -19.5% | ||
| Q1 25 | -0.3% | 82.5% | ||
| Q4 24 | -1.1% | -76.2% | ||
| Q3 24 | 0.9% | -27.7% | ||
| Q2 24 | -5.7% | -21.5% | ||
| Q1 24 | 0.8% | -21.6% |
| Q4 25 | -35.0% | -82.0% | ||
| Q3 25 | -1.9% | 7.5% | ||
| Q2 25 | -2.4% | -36.3% | ||
| Q1 25 | -0.2% | 73.7% | ||
| Q4 24 | -1.2% | -30.9% | ||
| Q3 24 | 0.8% | -54.2% | ||
| Q2 24 | -4.7% | -53.1% | ||
| Q1 24 | 0.7% | -43.6% |
| Q4 25 | $-2.56 | $-1.63 | ||
| Q3 25 | $-0.15 | $0.20 | ||
| Q2 25 | $-0.20 | $-0.83 | ||
| Q1 25 | $-0.02 | $10.04 | ||
| Q4 24 | $-0.13 | $-0.85 | ||
| Q3 24 | $0.08 | $-1.39 | ||
| Q2 24 | $-0.47 | $-1.29 | ||
| Q1 24 | $0.08 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $-205.3M |
| Total Assets | $449.0M | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $1.9B | ||
| Q3 25 | $99.1M | $1.7B | ||
| Q2 25 | $81.2M | $2.0B | ||
| Q1 25 | $80.7M | $2.0B | ||
| Q4 24 | $81.6M | $1.1B | ||
| Q3 24 | $64.0M | $1.0B | ||
| Q2 24 | $69.6M | $1.1B | ||
| Q1 24 | $5.2M | $884.8M |
| Q4 25 | $322.8M | $-205.3M | ||
| Q3 25 | $408.1M | $-155.8M | ||
| Q2 25 | $412.2M | $-206.5M | ||
| Q1 25 | $418.2M | $-185.8M | ||
| Q4 24 | $419.0M | $-1.1B | ||
| Q3 24 | $424.7M | $-1.1B | ||
| Q2 24 | $433.3M | $-980.2M | ||
| Q1 24 | $462.4M | $-893.9M |
| Q4 25 | $449.0M | $2.9B | ||
| Q3 25 | $538.2M | $2.6B | ||
| Q2 25 | $553.8M | $2.6B | ||
| Q1 25 | $576.2M | $2.7B | ||
| Q4 24 | $589.3M | $1.7B | ||
| Q3 24 | $597.4M | $1.8B | ||
| Q2 24 | $602.9M | $1.9B | ||
| Q1 24 | $648.4M | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $-34.3M |
| Free Cash FlowOCF − Capex | $16.1M | $-36.6M |
| FCF MarginFCF / Revenue | 6.8% | -22.3% |
| Capex IntensityCapex / Revenue | 0.9% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $-34.3M | ||
| Q3 25 | $20.1M | $-66.3M | ||
| Q2 25 | $4.2M | $-58.3M | ||
| Q1 25 | $5.7M | $870.1M | ||
| Q4 24 | $24.2M | $-30.0M | ||
| Q3 24 | $7.5M | $-77.0M | ||
| Q2 24 | $82.4M | $-71.5M | ||
| Q1 24 | $6.0M | $70.8M |
| Q4 25 | $16.1M | $-36.6M | ||
| Q3 25 | $17.9M | $-69.7M | ||
| Q2 25 | $2.3M | $-59.6M | ||
| Q1 25 | $3.8M | $868.4M | ||
| Q4 24 | $21.7M | $-33.8M | ||
| Q3 24 | $6.3M | $-77.5M | ||
| Q2 24 | $79.6M | $-78.8M | ||
| Q1 24 | $3.8M | $61.2M |
| Q4 25 | 6.8% | -22.3% | ||
| Q3 25 | 7.2% | -33.1% | ||
| Q2 25 | 0.8% | -33.3% | ||
| Q1 25 | 1.3% | 73.8% | ||
| Q4 24 | 7.0% | -15.8% | ||
| Q3 24 | 2.0% | -39.4% | ||
| Q2 24 | 23.4% | -42.2% | ||
| Q1 24 | 1.0% | 29.1% |
| Q4 25 | 0.9% | 1.4% | ||
| Q3 25 | 0.9% | 1.6% | ||
| Q2 25 | 0.7% | 0.7% | ||
| Q1 25 | 0.6% | 0.1% | ||
| Q4 24 | 0.8% | 1.8% | ||
| Q3 24 | 0.4% | 0.3% | ||
| Q2 24 | 0.8% | 4.0% | ||
| Q1 24 | 0.6% | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
PTCT
Segment breakdown not available.
